Show simple item record

dc.contributor.authorKirova, Y.
dc.contributor.authorTallet, A.
dc.contributor.authorAznar, Marianne Camille
dc.contributor.authorLoap, P.
dc.contributor.authorBouali, A.
dc.contributor.authorBourgier, C.
dc.date.accessioned2020-09-16T11:57:56Z
dc.date.available2020-09-16T11:57:56Z
dc.date.issued2020en
dc.identifier.citationKirova Y, Tallet A, Aznar MC, Loap P, Bouali A, Bourgier C. Radio-induced cardiotoxicity: From physiopathology and risk factors to adaptation of radiotherapy treatment planning and recommended cardiac follow-up. Cancer Radiother. 2020.en
dc.identifier.pmid32830054en
dc.identifier.doi10.1016/j.canrad.2020.07.001en
dc.identifier.urihttp://hdl.handle.net/10541/623255
dc.description.abstractCancer and cardiovascular disease (CVD) are the leading cause of mortality worldwide, and breast cancer (BC) the most common malignancy affecting women worldwide. Radiotherapy is an important component of BC treatment and participates in CVD occurrence. It seems, therefore, crucial to gather both radiation oncology and cardiology medical fields to improve the follow-up quality of our BC patients. This review aims at updating our knowledge regarding cardiotoxicities risk factors, and consequently, doses constraints in case of 3D-conformal and IMRT treatment planning. Then we will develop how to reduce cardiac exposure and what kind of cardiac follow-up we could recommend to our breast cancer patients.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.canrad.2020.07.001en
dc.titleRadio-induced cardiotoxicity: From physiopathology and risk factors to adaptation of radiotherapy treatment planning and recommended cardiac follow-upen
dc.typeArticleen
dc.contributor.departmentDepartment of radiation oncology, institut Curie, 75005 Paris, France.en
dc.identifier.journalCancer Radiotherapieen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record